Frank E. Thomas, COO, Interim CEO and President at AMAG PHARMACEUTICALS INC. (AMAG), bought 500 shares at $15.81 ($8K) on 2012-03-01, disclosed to the SEC on 2012-03-02.
Scheduled purchase ($8k) by COO, Interim CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ORTX | BUY | 2022-04-04 | $8K | — | Filing → |
| AMAG | SELL | 2015-08-07 | $1.0M | — | Filing → |
| AMAG | SELL | 2015-06-08 | $1.4M | — | Filing → |